Higher max dose guidance for semaglutide offers hope

A new study increases max-dose guidance for semaglutide. This offers hope for those who didn't reach their weight goals. The Injection and Infusion Clinic of ABQ now provides higher-dose weight loss injections, backed by the STEP UP trial, which showed 20.7% average weight loss with higher-dose semaglutide. 33.2% of participants lost over 25% of their body weight. Ideal for those who plateaued, this science-backed treatment supports long-term weight management with personalized care.
Albuquerque, NM - Feb 10, 2025 - The Injection and Infusion Clinic of ABQ is excited to announce the availability of new higher-dose weight loss injections as supported by the recent findings of the STEP UP clinical trial. These advanced treatment options are now available to patients in Albuquerque and beyond, offering renewed hope for those who didn't achieve results previously on the standard doses.

The STEP UP trial, a pivotal 72-week study, demonstrated remarkable outcomes for patients using the higher-dose semaglutide. Participants experienced an average of 20.7% total body weight loss, significantly exceeding the results seen with the standard 2.4 mg dose. This new dosing option is a game-changer for individuals seeking long-term, effective solutions to manage their weight and improve overall health.

"The STEP UP trial results are a major breakthrough in the field of weight loss," said KC Raver, Clinic Director at The Injection and Infusion Clinic of ABQ. "We're thrilled to bring this innovative treatment to our patients, especially those who've felt stuck in their weight loss journey or haven't seen success with other methods. These higher doses of semaglutide offer a proven, evidence-based solution to help people achieve their health goals."

Why Choose Higher-Dose Semaglutide?

Patients who previously didn't see results or experienced plateaus can now benefit from this enhanced treatment option. Key benefits of the higher-dose semaglutide include:

*
Greater Weight Loss: Patients in the STEP UP trial achieved an average weight reduction of 20.7% - a significant improvement over standard-dose therapies.

*
Increased Success: 33.2% of participants on the higher dose lost 25% or more of their body weight, compared to 16.7% with the 2.4 mg dose.

*
Science-Backed Results: Clinical evidence highlights the safety and effectiveness of this higher dose, offering new hope for patients who felt like they'd exhausted other options.

Semaglutide is a GLP-1 receptor agonist, a class of medications originally developed for diabetes management that has also been shown to support weight loss. These medications work by regulating appetite and glucose metabolism. The findings of the STEP UP study suggest that higher doses may be beneficial for individuals who have plateaued in their weight loss journey or did not achieve desired results with lower doses.

"The results of this study provide additional data on how higher doses of semaglutide may impact weight loss outcomes," said KC Raver, Clinic Director at The Injection and Infusion Clinic of ABQ. "Offering this option allows us to tailor treatments based on emerging clinical evidence and patient needs."

The Injection and Infusion Clinic of ABQ integrates evidence-based weight management strategies with individualized patient care. Those interested in learning more about the higher-dose semaglutide treatment can schedule a consultation to discuss their options.

For more information, visit http://www.infusionclinicabq.com/semaglutide or call 505.445.4300.

About The Injection and Infusion Clinic of ABQ

The Injection and Infusion Clinic of ABQ specializes in weight management and wellness solutions, offering treatments backed by clinical research. With a commitment to personalized care, the clinic empowers patients to achieve lasting health outcomes.

Contact:

The Injection and Infusion Clinic of ABQ

Phone: 505.506.7775

Email: kc@welllifeabq.com

Website: www.infusionclinicabq.com

Media Contact
Company Name: Well Life ABQ
Contact Person: KC Raver
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=higher-max-dose-guidance-for-semaglutide-offers-hope]
Phone: 505-506-7775
Address:8400 Osuna Rd, NE Suite 5C
City: Albuquerque
State: NM
Country: United States
Website: http://www.welllifeabq.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.